S.H.N. Financial Investments Ltd. - 14 Aug 2025 SCHEDULE 13G/A Report for Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA)

Filing Manager: S.H.N. Financial Investments Ltd.
Reporting Manager: S.H.N. Financial Investments Ltd.
Security: Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol: HEPA
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 18:45:57 UTC
Date of event: 14 Aug 2025
Previous filing: 27 Jan 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
S.H.N. Financial Investments Ltd.	0%	0	0	0	/s/ Nir Shamir	Nir Shamir, Chief Executive Officer